- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
The Thyroxine Binding Globulin (TBG) Test is a type of in vitro diagnostic test used to measure the amount of TBG in a patient's blood. TBG is a protein produced by the liver that binds to the thyroid hormone thyroxine, and is used to regulate the body's metabolism. Abnormal levels of TBG can indicate a variety of thyroid disorders, including hypothyroidism and hyperthyroidism.
The TBG Test market is a subset of the larger in vitro diagnostics market, which is estimated to be worth billions of dollars. The TBG Test market is expected to grow in the coming years due to the increasing prevalence of thyroid disorders, as well as the development of new technologies and products.
Some of the major companies in the TBG Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. These companies offer a variety of TBG Test products, including immunoassays, ELISA kits, and automated systems. Show Less Read more